Skip to content

PolitiKit

Raymond Shelley's lobbying: the registrations they file and every meeting they've reported since November 2021.

← Lobbying

Registrant (responsible officer)

Raymond Shelley

President, Apotex Canada

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament
4
Since Nov 2021
4
Active registrations
0

Reported meetings

  • Apotex Inc.
    • Justine Frame · Policy Advisor, Health Canada (HC)
    • Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
    • Shahad Khalladi · Senior Policy Advisor, Health Canada (HC)
    Pharmaceutical policy: Ongoing interactions related to increased and sustainable utilization of cost-saving generic and biosimilar medicines, and a predictable and viable business environment for generic medicines. Read more

    Domestic pharmaceutical manufacturing: trade, tariffs, and sustainability of domestic manufacturing.

    Official report

  • Apotex Inc.
    and 4 more
    • Guillaume Couillard · Director General, Patented Medicine Prices Review Board (PMPRB)
    • Rodrigo Arancibia · Sr Director, Innovation, Science and Economic Development Canada (ISED)
    • Loris Mirella · Director - Intellectual Property Trade Policy, Global Affairs Canada (GAC)
    • Arianne Reza · Deputy Minister of Public Services and Procurement, Public Services and Procurement Canada (PSPC)
    Domestic pharmaceutical manufacturing: trade, tariffs, and sustainability of domestic manufacturing. Read more

    Pharmaceutical policy: Ongoing interactions related to increased and sustainable utilization of cost-saving generic and biosimilar medicines, and a predictable and viable business environment for generic medicines.

    Official report

  • Apotex Inc.
    • Yash Nanda · Policy Advisor, Prime Minister's Office (PMO)
    Domestic pharmaceutical manufacturing: trade, tariffs, and sustainability of domestic manufacturing. Read more

    Pharmaceutical policy: Ongoing interactions related to increased and sustainable utilization of cost-saving generic and biosimilar medicines, and a predictable and viable business environment for generic medicines.

    Official report

  • Apotex Inc.
    • Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
    Domestic pharmaceutical manufacturing: trade, tariffs, and sustainability of domestic manufacturing. Read more

    Pharmaceutical research & development -support for R&D in Canada.

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.